Top picks for online diabetes information for doctors and patients
Sites for type 2 diabetes
Dr. Hirsch recommended several sites for patients with type 2 diabetes, including:
- The Johns Hopkins Patient Guide to Diabetes, one of his favorite type 2 diabetes sites because of its “artistry, the graphics – you get it from just looking at the pictures. There’s a tech corner, videos, and patient stories. There’s just a lot here for patients.”
- Diabetes Sisters, specifically for women with diabetes.
- Diabetes Strong, which focuses on exercise.
- Wildly Fluctuating, with topics “from humor to serious stuff to miscellaneous musings on the diabetes news of the week by a type 2 diabetes patient/expert.”
Sites for clinicians
For clinicians, Dr. Hirsch said the following sites provide free and up-to-date information on the management of type 2 diabetes (some also include type 1 diabetes):
- ADA/EASD Standards of Care.
- Diabetes Canada 2018 Guidelines.
- American Association of Clinical Endocrinologists Type 2 Diabetes Management Algorithm.
- UK National Institute for Health and Care Excellence, which Dr. Hirsch called “extensive evidence-based guidelines. They really dig into the evidence as much, if not more, than most of the national standards of care around the world.”
- Clinical Diabetes, an ADA journal that provides “outstanding articles geared for nonspecialists free to clinicians online 6 months after publication.” It includes some primary data articles, but it is mostly review, he noted.
Regional sites
Dr. Hirsch included information about regional sites as well:
- Dr. Mohan’s Diabetes Specialties Centre, “a very good site for those living in India.”
- HealthDirect in Australia.
- Diabetes UK.
Dr. Hirsch is a consultant for Abbott Diabetes Care, Roche, and Bigfoot; conducts research for Medtronic; and is an editor on diabetes for UpToDate. Dr. Maahs has received research support from the National Institutes of Health, JDRF, National Science Foundation, and Leona M. and Harry B. Helmsley Charitable Trust and has consulted for Abbott, Helmsley, Sanofi, Novo Nordisk, Eli Lilly, and Insulet.
A version of this story originally appeared on Medscape.com.
